Purchase Short-Term Access
Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes
Lorraine Lipscombe, MD, MSc, FRCPC
Annals of Internal Medicine 2009;150:JC4-8.
doi:10.7326/0003-4819-150-8-200904210-02008
Purchase Online access to this article for 24 hours
